- Home
- ECOR vs ETHZW Comparison
ECOR vs ETHZW Comparison
Compare ECOR & ETHZW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- ETHZW
- Stock Information
- Founded
- ECOR 2005
- ETHZW N/A
- Country
- ECOR United States
- ETHZW United States
- Employees
- ECOR 62
- ETHZW N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ETHZW Biotechnology: Pharmaceutical Preparations
- Sector
- ECOR Health Care
- ETHZW Health Care
- Exchange
- ECOR Nasdaq
- ETHZW Nasdaq
- Market Cap
- ECOR 39.6M
- ETHZW 35.3M
- IPO Year
- ECOR 2018
- ETHZW 2017
- Fundamental
- Price
- ECOR $4.74
- ETHZW $0.01
- Analyst Decision
- ECOR Strong Buy
- ETHZW
- Analyst Count
- ECOR 2
- ETHZW 0
- Target Price
- ECOR $25.50
- ETHZW N/A
- AVG Volume (30 Days)
- ECOR 39.5K
- ETHZW N/A
- Earning Date
- ECOR 11-05-2025
- ETHZW N/A
- Dividend Yield
- ECOR N/A
- ETHZW N/A
- EPS Growth
- ECOR N/A
- ETHZW N/A
- EPS
- ECOR N/A
- ETHZW N/A
- Revenue
- ECOR $27,700,000.00
- ETHZW N/A
- Revenue This Year
- ECOR $24.55
- ETHZW N/A
- Revenue Next Year
- ECOR $41.13
- ETHZW N/A
- P/E Ratio
- ECOR N/A
- ETHZW N/A
- Revenue Growth
- ECOR 30.16
- ETHZW N/A
- 52 Week Low
- ECOR $4.16
- ETHZW N/A
- 52 Week High
- ECOR $19.49
- ETHZW N/A
- Technical
- Relative Strength Index (RSI)
- ECOR 42.03
- ETHZW N/A
- Support Level
- ECOR $4.88
- ETHZW N/A
- Resistance Level
- ECOR $5.17
- ETHZW N/A
- Average True Range (ATR)
- ECOR 0.24
- ETHZW 0.00
- MACD
- ECOR -0.00
- ETHZW 0.00
- Stochastic Oscillator
- ECOR 35.06
- ETHZW 0.00
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.